Cardiovascular and metabolic diseases including obesity remain important areas of unmet medical need, and we plan to continue applying our global capabilities to advance a pipeline of investigational treatments that have the potential to fill critical gaps in patient care, including continued development of our oral GIPR antagonist candidate and other earlier obesity programs, said Chris Boshoff, MD, PhD, Chief Scientific Officer and President, Research and Development at Pfizer
Is compounded semaglutide from PlexusDx as safe as brand-name Ozempic or Wegovy
Kocherga Meditsinskiy sovet = Medical Council .2026
That's All Protein meets all these criteria with just 4-7 organic ingredients
But there have also been concerns about safety
Using immunofluorescence, we could not detect GLP-1R in astrocyte cell bodies or main processes (Supplementary Fig